CHURCH & DWIGHT CO INC /DE/

Listed Company

CHDCIK 0000313927NYSELarge AcceleratedSoap, Detergents, Cleang Preparations, Perfumes, CosmeticsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$6.20B

Net Income

$736.80M

Total Assets

$8.91B

Equity

$4.00B

Shares Out

236.69M

Op. Cash Flow

$1.22B

Business

CHURCH & DWIGHT CO INC /DE/ develops, manufactures and markets a broad portfolio of consumer household and personal care products and specialty products serving animal and food production, industrial chemical and cleaning markets. Its main products include baking soda-based household cleaners and deodorizers, laundry detergents, stain removers, oral care, personal care and OTC items, dietary supplements, water flossers, and specialty animal nutrition and chemical products under well-known brands. The company operates three segments: Consumer Domestic, Consumer International, and Specialty Products Division. It distributes products through supermarkets, mass merchandisers, drugstores, wholesale clubs, specialty and discount retailers, e-commerce channels, subsidiaries and third‑party distributors across the U.S. and international markets.

Summary from filing dated 2025-02-13

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net Sales	6,203	6,107	5,868	5,376	5,190
Cost of sales	3,428	3,317	3,279	3,126	2,927
Gross Profit	2,775	2,790	2,589	2,250	2,264
Marketing expenses	709	698	641	535	578
Selling, general and administrative expenses	988	928	890	706	607
VMS Trade name and other asset impairments	—	357	—	—	—
Income from Operations	1,078	807	1,057	598	1,079
Equity in earnings of affiliates	8	9	9	12	9
Interest income	24	26	13	4	—
Interest expense	−95	−95	−111	−90	−55
Other income (expense), net	−57	9	−800,000	−1	−2
Income before Income Taxes	957	756	967	523	1,032
Income taxes	220	171	212	109	204
Net Income	737	585	756	414	828
Weighted average shares outstanding - Basic	243	244	245	243	245
Weighted average shares outstanding - Diluted	244	247	248	246	250
Net income per share - Basic	3.04	2.39	3.09	1.7	3.38
Net income per share - Diluted	3.02	2.37	3.05	1.68	3.32
Cash dividends per share	1.18	1.13	1.09	1.05	1.01

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	409	964	345	270	241
Accounts receivable, less allowances of $3.7 and $5.1	593	601	527	422	406
Inventories	535	613	613	647	535
Other current assets	60	62	45	57	52
Total Current Assets	1,597	2,241	1,530	1,396	1,233
Property, Plant and Equipment, Net	823	932	928	761	653
Equity Investment in Affiliates	10	11	12	13	9
Trade Names and Other Intangibles, Net	3,512	2,889	3,302	3,432	3,494
Goodwill	2,628	2,433	2,432	2,427	2,275
Other Assets	343	378	366	318	333
Total Assets	8,912	8,883	8,569	8,346	7,997
Accounts payable	732	705	631	667	—
Accrued expenses and other liabilities	583	606	580	436	—
Business acquisition liabilities	179	0	—	—	—
Income taxes payable	3	5	7	7	3
Total Current Liabilities	1,498	1,316	1,422	1,184	2,075
Long-term Debt	2,205	2,205	2,202	2,600	2,202
Deferred Income Taxes	887	669	743	757	745
Deferred and Other Long-term Liabilities	321	333	314	273	298
Total Liabilities	4,910	4,522	4,714	4,856	4,763
Commitments and Contingencies	—	—	—	—	—
Preferred Stock, $1.00 par value, Authorized 2,500,000 shares; none issued	0	0	0	0	0
Common Stock, $1.00 par value, Authorized 600,000,000 shares; 293,709,982 shares issued as of December 31, 2025 and 2024	294	294	294	294	293
Additional paid-in capital	625	563	455	366	310
Retained earnings	6,768	6,320	6,012	5,525	5,366
Accumulated other comprehensive loss	−20	−31	−27	−29	−68
Common stock in treasury, at cost: 57,156,105 shares as of December 31, 2025 and 47,830,141 shares as of December 31, 2024	−3,665	−2,785	−2,878	−2,665	−2,668
Total Stockholders' Equity	4,002	4,361	3,855	3,490	3,233
Total Liabilities and Stockholders Equity	8,912	8,883	8,569	8,346	7,997

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation expense	90	83	73	67	68
Amortization expense	158	156	152	152	151
Change in fair value of business acquisition liabilities	19	0	0	—	—
Deferred income taxes	36	−82	−14	−118	20
Business exit related impairments	46	0	0	—	—
Loss on sale of vitamin business	59	0	0	—	—
Equity in net earnings of affiliates	−8	−9	−9	−12	−9
Distributions from unconsolidated affiliates	9	9	10	9	9
Non-cash compensation expense	58	59	64	32	24
Asset impairment charge and other asset write-offs	10	12	9	2	15
Other	−7	−6	−400,000	−3	4
Subtotal	1,206	1,164	1,040	—	—
Accounts receivable	39	−82	−97	−5	2
Inventories	56	2	39	−93	−29
Other current assets	1	−500,000	10	3	−6
Accounts payable	2	99	−58	7	—
Accrued expenses	−61	−1	113	33	—
Income taxes payable	−5	−7	−2	14	−16
Other operating assets and liabilities, net	−23	−19	−14	−28	−16
Change in Working Capital	10	−8	−9	—	—
Net Cash Provided By Operating Activities	1,215	1,156	1,031	885	994
Additions to property, plant and equipment	−122	−180	−224	−179	−119
Acquisitions	−656	−20	0	−547	−556
Proceeds from Sale of Passport	0	7	0	0	0
Proceeds from Sale of Vitamin Business	160	0	0	—	—
Other	1	10	−11	−3	−7
Net Cash Used In Investing Activities	−617	−183	−234	−729	−682
Repayments of long-term debt	0	−205	−200	−700	−300
Short-term debt (repayments), net of borrowings	0	−4	−71	−179	−99
Proceeds from stock options exercised	36	143	112	26	99
Payment of cash dividends	−287	−277	−267	−255	−248
Purchase of treasury stock	−900	0	−300	0	−500
Payment of business acquisition liability	−6	0	0	—	—
Other	−5	−1	−100,000	—	—
Net Cash Used In Financing Activities	−1,162	−343	−726	−121	−252
Effect of exchange rate changes on cash and cash equivalents	9	−10	4	−6	−2
Net Change In Cash and Cash Equivalents	−555	620	74	30	58
Interest (net of amounts capitalized)	95	94	112	86	52
Income taxes	188	260	228	213	203
Property, plant and equipment expenditures included in Accounts Payable	17	11	31	14	11

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro